American Portfolios Advisors Supernus Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,044 shares of SUPN stock, worth $66,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,044Holding current value
$66,797% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$340 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$201 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$158 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$94.1 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$85.9 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.75B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...